Building a Better Vector: The Manipulation of AAV Virions
Top Cited Papers
- 1 December 2000
- Vol. 278 (2) , 301-308
- https://doi.org/10.1006/viro.2000.0707
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus VectorsJournal of Virology, 2000
- Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate MuscleJournal of Virology, 2000
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)Journal of Medical Virology, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2 antibodyNature Biotechnology, 1999
- New developments in the generation of Ad-free, high-titer rAAV gene therapy vectorsNature Medicine, 1997
- Transfer of Contaminants in Adeno-Associated Virus Vector Stocks Can Mimic Transduction and Lead to Artifactual ResultsHuman Gene Therapy, 1997
- A SEROEPIDEMIOLOGIC STUDY OF ADENOVIRUS-ASSOCIATED VIRUS INFECTION IN INFANTS AND CHILDRENAmerican Journal of Epidemiology, 1971